Cryo-Cell International, Inc. (CCEL) Price to Earnings Ratio

Corporate emblem and logo of Cryo-Cell (CCEL)

Cryo-Cell International (CCEL) is a leader in the private biobanking sector, developing regenerative services in collaboration with Duke University; this market valuation shown on GURU.Markets currently stands at -22.70. The company generates its primary revenue from the cryopreservation of client tissues and umbilical cord blood. High costs associated with the transfer of biomaterials provide the firm with pricing power, allowing it to regularly increase storage cell rental rates.

CCEL - Cryo-Cell International, Inc. Price to Earnings Ratio over the range 07/04/2022 - 11/13/2026

Analytical breakdowns for Cryo-Cell International

- market price and analyst price targets:
Market Price Cryo-Cell International Inc|CCEL - Price Target Chart
- market capitalization details:
Market Value Cryo-Cell International, Inc.|CCEL - Total Company Value
- book capitalization information:
Net Assets per Single Share Cryo-Cell International|CCEL - Company Book Value|Market Capitalization to Book Value cryo-cell.com|CCEL - Company Total Assets
- company liabilities and liquidity data:
Total Debt to Equity Ratio Cryo-Cell International|CCEL - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Cryo-Cell International Inc|CCEL - Company Total Debt|Debts to Book Value Cryo-Cell International, Inc.|CCEL - Company Long-Term Debt|Short-Term Debt Cryo-Cell International|Critical Liquidity cryo-cell.com
- earnings and market ratios statistics:
CCEL - Net Profit|Future Profit Cryo-Cell International|CCEL - P/E Multiple|Projected Price to Earnings Ratio Cryo-Cell International Inc|CCEL - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Cryo-Cell International, Inc.|CCEL - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months Cryo-Cell International|CCEL - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months cryo-cell.com|CCEL - Earnings growth in current year|Consensus forecast of earnings per share growth for next year Cryo-Cell International
- sales volume and revenue indicators:
CCEL - Company Revenue|Company Revenue Forecast Cryo-Cell International Inc|CCEL - Market Cap to Revenue|Price to Expected Revenue Ratio Cryo-Cell International, Inc.
General company analysis:CCEL (cryo-cell.com)
Signature product of Cryo-Cell International

Stable storage payments for biomaterials at Cryo-Cell International (CCEL) make the P/E ratio dynamics on GURU.Markets an indicator of the business's real value relative to its cash flow. The ratio of market capitalization to net income shows how many years an investor is willing to wait for a return on investment, allowing for a distinction between a fair valuation and a dangerous overpricing amid stagnant operational metrics.

Analysis of competing companies

Market Cap to Earnings mesoblast.com MESO|Price to Earnings Ratio Lineage Cell Therapeutics, Inc. (LCTX)|Price to Earnings Ratio SRZN (Surrozen Inc)|Price to Earnings Ratio FibroBiologics FBLG|Longeveron Corporation - Price to Earnings Ratio|BRTX - Price to Earnings Ratio|Business Payback Period Creative Medical Technology CELZ